Catherine M. Szyman, CVP, Critical Care at Edwards Lifesciences Corp (EW), sold 19,482 shares at $110.24 ($2.2M) on 2021-10-18, disclosed to the SEC on 2021-10-18.
Seasonal sale ($2.2M) by CVP, Critical Care — this insider has traded EW in October in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $110.24 | 7,138 | $787K | 36.6% |
| 2 | $110.24 | 7,138 | $787K | 36.6% |
| 3 | $110.87 | 2,603 | $289K | 13.4% |
| 4 | $110.87 | 2,603 | $289K | 13.4% |
| Total | $110.41 avg | 19,482 | $2.2M | 100% |
| Filing → |
| EW | SELL | 2023-09-08 | $380K | — | Filing → |
| EW | SELL | 2023-08-09 | $393K | — | Filing → |
| EW | SELL | 2023-07-10 | $453K | — | Filing → |